Research progress of myelosuppression after chemotherapy for lung cancer
Lung cancer,as one of the malignant tumors with the highest morbidity and mortality in the world,is still a threat to human life and health.Chemotherapy is the most basic and important treatment for lung cancer,and the most well-known adverse reaction is myelosuppression.Myelosuppression will cause anemia,bleeding and decrease of immune mechanism in patients with chemotherapy,which will interrupt the course of chemotherapy or reduce the amount of chemotherapeutic drugs,which will effect the efficacy of chemotherapy.Severe myelosuppression can even lead to death.In this paper,the definition,mechanism,treatment and risk factors of myelosuppression in patients with lung cancer after chemotherapy are described to further strengthen the understanding of myelosuppression after chemotherapy for lung cancer.